603538.SS
Price:
$13.48
Market Cap:
$2.86B
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. It offers APIs, intermediates, and formulations for the treatment of cardiovascular, central nervous, respiratory, antitumor, anti-infection, digestive, and geriatric diseases, as well as antiviral. The company was founded in 2004 and is headquartered in Ningbo, China.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-04-10
Stock Exchange
SHH
Ticker
603538.SS
According to Ningbo Menovo Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 3.11%. This represents a change of 301.40% compared to the average of 0.77% of the last 4 quarters.
The mean historical ROE of Ningbo Menovo Pharmaceutical Co., Ltd. over the last ten years is 8.52%. The current 3.11% ROE has changed -63.48% with respect to the historical average. Over the past ten years (40 quarters), 603538.SS's ROE was at its highest in in the March 2022 quarter at 6.03%. The ROE was at its lowest in in the December 2023 quarter at -2.05%.
Average
8.52%
Median
9.09%
Minimum
0.55%
Maximum
16.25%
Discovering the peaks and valleys of Ningbo Menovo Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 451.26%
Maximum Annual ROE = 16.25%
Minimum Annual Increase = -96.60%
Minimum Annual ROE = 0.55%
Year | ROE | Change |
---|---|---|
2024 | 3.05% | 451.26% |
2023 | 0.55% | -96.60% |
2022 | 16.25% | 99.72% |
2021 | 8.14% | -19.04% |
2020 | 10.05% | -9.14% |
2019 | 11.06% | 37.45% |
2018 | 8.05% | 101.09% |
2017 | 4.00% | -64.97% |
2016 | 11.43% | -9.34% |
2015 | 12.60% | -7.29% |
The current ROE of Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.62%
5-year avg
7.61%
10-year avg
8.52%
Ningbo Menovo Pharmaceutical Co., Ltd.’s ROE is less than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (7.23%), greater than Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (-7.01%), less than Juewei Food Co., Ltd. (2.80%), less than Joinn Laboratories(China)Co.,Ltd. (0.93%), less than Zhejiang Starry Pharmaceutical Co.,Ltd. (0.63%),
Company | ROE | Market cap |
---|---|---|
7.23% | $12.27B | |
-7.01% | $17.77B | |
2.80% | $10.39B | |
0.93% | $10.78B | |
0.63% | $3.59B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ningbo Menovo Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ningbo Menovo Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ningbo Menovo Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)?
What is the highest ROE for Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)?
What is the 3-year average ROE for Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)?
What is the 5-year average ROE for Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)?
How does the current ROE for Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) compare to its historical average?